BioWorld

Feb. 7, 2006

View Archived Issues

QuatRx Files $86M IPO To Push Clinical Development

A month after starting its first Phase III trial, QuatRx Pharmaceuticals Co. filed for its initial public offering, hoping to raise $86.25 million. (BioWorld Today) Read More

Biotech Deals: Focusing On Pharma Relationships

Read More

ReNeuron's Results Positive As Stem Cell Meeting Starts

Read More

Bush's Proposed Budget Boosts FDA Funds In '07

Read More

Clinic Roundup

Read More

Other News To Note

Read More